Technical Analysis for ARCT - Arcturus Therapeutics Ltd.

Grade Last Price % Change Price Change
grade C 10.61 -0.09% -0.01
ARCT closed down 0.09 percent on Friday, September 13, 2019, on 1.25 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Flat Down
See historical ARCT trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Multiple of Ten Bullish Other 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Fell Below 20 DMA Bearish -0.09%
50 DMA Support Bullish -0.09%
NR7 Range Contraction -0.09%

Older signals for ARCT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Alcobra Ltd is a development-stage biopharmaceutical company. The Company is focused on development and commercialization of its lead product candidates, including MDX and ADAIR. MDX is a oral drug, for the treatment of ADHD and other cognitive disorders, including Fragile X. MDX is a combined rapid onset ER formulation of the chemical pyridoxine pyroglutamate, which is more commonly known as metadoxine. MDX consists of a single bi-layer oral tablet, which includes both a rapid onset release metadoxine formulation and a slow release metadoxine formulation together providing the desired dual release profile. The new extended-release formulation prolongs the human plasma levels of metadoxine for up to 12 hours, which results in enhanced efficacy benefits. ADAIR is an oral, semi-solid, liquid-filled, hard gelatin capsule of an abuse-deterrent IR formulation of dextroamphetamine sulfate, which is manufactured as 10 mg capsules.
Biopharmaceutical Pharmaceutical Industry Drugs Pharmacology Health Sciences Euphoriants Dosage Forms Cognitive Disorders Adhd Tablet
Is ARCT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.5
52 Week Low 4.11
Average Volume 91,192
200-Day Moving Average 7.2767
50-Day Moving Average 10.6247
20-Day Moving Average 10.876
10-Day Moving Average 10.91
Average True Range 0.965
ADX 12.68
+DI 18.0645
-DI 18.9521
Chandelier Exit (Long, 3 ATRs ) 9.0299
Chandelier Exit (Short, 3 ATRs ) 11.405
Upper Bollinger Band 11.4849
Lower Bollinger Band 10.2671
Percent B (%b) 0.28
BandWidth 11.197131
MACD Line 0.0803
MACD Signal Line 0.1353
MACD Histogram -0.055
Fundamentals Value
Market Cap 1.68 Billion
Num Shares 158 Million
EPS -0.56
Price-to-Earnings (P/E) Ratio -18.95
Price-to-Sales 11.42
Price-to-Book 2.04
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.15
Resistance 3 (R3) 12.10 11.54 11.89
Resistance 2 (R2) 11.54 11.15 11.57 11.81
Resistance 1 (R1) 11.08 10.91 10.80 11.12 11.72
Pivot Point 10.51 10.51 10.37 10.54 10.51
Support 1 (S1) 10.05 10.12 9.77 10.10 9.50
Support 2 (S2) 9.49 9.88 9.51 9.41
Support 3 (S3) 9.02 9.49 9.33
Support 4 (S4) 9.07